Dr. Ming He Joins COTA as Senior Medical Director

Today, we are excited to announce the newest addition to our team: Dr. Ming He, COTA’s Senior Medical Director. At COTA, Dr. He will work across the organization, applying her clinical oncology expertise to support various teams including abstraction operations, engineering, product, and analytics.

COTA Team Member Spotlight: Chew Lee

For our April Team Member Spotlight, we are excited to recognize Chew Lee, a Software Engineer on COTA’s engineering team. In addition to his official role as a Software Engineer, Chew also holds the position of being COTA’s Chief Celebration Officer, a role that has become increasingly important as the company adjusts to a completely remote work environment.

Historical Regulatory Use of RWE

Historical uses of RWE in regulatory decision-making are at best sparse, but they provide the precedent on which we are building the foundation of real-world impact. This blog reviews use cases of RWE in regulatory actions.

COVID-19 & COTA: Perspectives from Mike Doyle, CEO

Reflecting on the weeks ahead as we try to prevent the spread of COVID-19, COTA’s CEO Mike Doyle shares some of the things we’re doing to support our team members at COTA, and highlights promising industry developments.

COTA Team Member Spotlight: Irfan Shah

For this month’s Team Member Spotlight, we are excited to introduce you to Irfan Shah! Irfan joined COTA in 2016 and is the company’s Director of Strategy and Business Development for life sciences.

White Paper: Real-World Evidence Reflections and Predictions

Novel sources and growing volumes of data are changing the way drugs are developed, evaluated, and brought to market. In the spirit of collaboration, COTA invited our partners from Pfizer and Bristol-Myers Squibb to share their unique perspectives as early adopters of real-world evidence.